Aveo Oncology Is A Biopharmaceutical Company Focused On Developing And Commercializing Targeted Cancer Therapiesas A Subsidiary Of Lg Chem Ltdaveo Aims To Improve Patientsquality Of Life By Addressing Unmet Medical Needs In Oncologythe Company Specializes In Precision Oncologyutilizing Proprietary Technologies Such As Its Human Response Prediction Platform To Identify And Validate Drug Targets Aveo Is Engaged In Drug Development Through Internal Research And Collaborations With Partners Like Lg Chem Life Sciences And Cue Biopharmaits Global Commercialization Efforts Include Marketing Products In The Useuicelandand Norwaythe Company S Approved Productfotivdaa Tivozanib Is A Vegfr Inhibitor For Treating Renal Cell Carcinomaaveo Also Has Several Pipeline Candidates In Various Stages Of Developmenttargeting Conditions Such As Head And Neck Squamous Cell Carcinoma And Cancer Cachexiathe Company Serves Adult Cancer Patients And Collaborates With Healthcare Providers To Enhance Drug Development And Market Access
